Background: The long-term health outcomes and costs of helicopter emergency
A: Introduction
In most Western countries, helicopter emergency medical services (HEMS) are available to provide on-scene assistance to trauma patients 1 . HEMS can be requested by the dispatch centre or by regular emergency medical services (EMS) already at the accident site. The type and quality of care provided by HEMS may differ depending on local (regional and national) circumstances, needs and appointments. Depending on these conditions, HEMS may be staffed by physicians, flight nurses or paramedics 2 . As these professionals have different levels of certification, they provide different therapeutic options to patients at the accident site. The utilization of HEMS may also differ as a result of topographical and infrastructural diversity (urban, rural or inaccessible areas) 3 . HEMS are used to cover long-distance patient contacts and to transport advanced life support to the scene of an accident, after which a patient is transported to hospital by ambulance or helicopter. Owing to limited conclusive literature, the health effects of HEMS remain uncertain. However, published reviews have reported positive effects of HEMS assistance on survival, as has also been observed in the Netherlands [4] [5] [6] [7] [8] .
Another important question is the cost of this care. It is well known that prehospital trauma care provided by HEMS is relatively expensive. In an era where healthcare cost savings have a high priority for governments, expensive treatment modalities and health services are monitored carefully.
Studies into the cost-effectiveness of HEMS are limited 4, [8] [9] [10] . To date, only two studies on survival and quality of life (QoL) in combination with costs per qualityadjusted life year (QALY) have been published 9, 11 . These two studies reported costs per QALY for HEMS of between €7300 and €37 700 (US $9300-47 900) 9, 11 . The use of costs per QALY as an outcome measure is important and allows comparison of the efficiency of different types of healthcare service with one another. It also may support decisions to restrict investment to services with costs per QALY below a predefined acceptance threshold. The acceptance of cost per QALY is, however, not an absolute figure. Policy-makers and healthcare economists have proposed that costs varying from €25 000 up to €75 000 (US $31 800-95 300) per QALY may be considered acceptable [12] [13] [14] .
In 1995, when HEMS were introduced in the Netherlands, a cost-effectiveness study was undertaken 11 . The Dutch trauma system has since been developed and now covers the entire country 15 . The organization of the trauma system, as well as the level of training of HEMS physicians, nurses and the trauma centre doctors, has improved since then. In consequence, a well designed study was needed to measure the effects of HEMS on survival and QoL. This cost-effectiveness analysis is presented here.
The study hypothesis was that the costs per QALY for HEMS in the Netherlands were below the acceptance threshold.
+A: Methods
For survival and cost calculations, data were collected from 1 January 2003 to 31
December 2006. During this 4-year study period a prospective cohort study was conducted that included all consecutive patients with polytrauma aged over 13 years with an Injury Severity Score (ISS) 16 greater than 15, who were admitted to the emergency department of a level I trauma centre. Patients identified as dead on arrival at the scene of the accident were excluded from the study.
Data were extracted from the trauma registry, which includes the same variables as in the Major Trauma Outcome Study (MTOS) database 1 (age, Glasgow Coma Scale (GCS) 17 score, Revised Trauma Score (RTS) 18 , mechanism of trauma and details of injuries). Missing data were obtained from the original ambulance charts.
All patients receiving on-scene EMS and HEMS assistance were included in the HEMS group. Patients treated only by EMS services were included in the EMS group.
+B: Survival calculations
Estimated survival was determined with the Trauma Injury Severity Score (TRISS) method, which includes the 'predicted mortality' 19 . The TRISS (logistic regressionbased) method is the multivariable approach of choice 20 . The coefficients used in the TRISS model are derived from the MTOS 1 . To compare case mix between the regular MTOS population and this study population, the M statistic must be calculated.
Although M does not follow a specific distribution, it is generally considered acceptable to apply the uncorrected TRISS when M is 0.88 or higher 21 . As the value of M in the authors' population was 0.38, a custom-fitted regression model was used to calculate predicted survival. Construction of the logistic regression was analogous to the method described by Frankema and colleagues 
+B: Quality-of-life measurements
The EuroQol -Five Dimensions (EQ-5D) was used as a generic measure to determine health status 2 years after trauma. The EQ-5D is generally recommended for economic evaluation of trauma care at a consensus conference 22 . A domain-related scoring algorithm based on empirical valuations from the UK general population and subsequent statistical modelling is available, by means of which each health status description can be expressed as a utility score 23 . This summary score ranges on a scale 
+B: Discounting
It is generally accepted practice in economic evaluations to discount future costs and benefits arising from healthcare interventions to reflect individuals' and society's time preference 25 . To compare the benefits that occur over time, benefits occurring in future years must be adjusted to relate to the 'present value' in which the costs are spent. A discount rate of 1.5 per cent for the benefits was used, as recommended in the Dutch guidelines for economic evaluations in this study 26 .
+B: Statistical analysis
As discount rates vary over time and across countries, the effect of using different discount rates on the results obtained by sensitivity analysis was determined. An annual discount rate of 0 and 3.5 per cent for benefits was used because the rate of 3.5
per cent was recommended by the National Institute for Health and Clinical
Excellence. Statistical analyses were performed using SPSS ® version 12.0 (SPSS, Chicago, Illinois, USA). P<0.050 was considered statistically significant.
+A: Results

+B: Effect of helicopter emergency medical services assistance on survival
During the 4-year study interval, 781 patients were admitted to the emergency department of a level I trauma centre. The majority of patients were men (72.6 per cent) and sustained blunt force trauma (91.3 per cent) ( . No statistically significant differences in quality of life were found between patients assisted by HEMS and those assisted by EMS. Two years after trauma, the mean EQ-5D utility score was 0.70 versus 0.71 respectively, and the prevalence of physical and physiological limitations for the total patient population was high for all EQ-5D dimensions (mobility, 43.9 per cent; self-care, 18.9 per cent; usual activities, 54.6 per cent; pain and discomfort, 61.4 per cent; anxiety and depression, 40.2 per cent) (Fig. 1 ). There were no significant differences between the two groups for any of the separate health domains measured with the EQ-5D. On some dimensions (mobility, self-care and usual activities) the prevalence of limitations was slightly lower for HEMS than for EMS assistance, but for the others (pain, anxiety/depression and emotion) the reverse was found.
+B: Costs
The average medical treatment costs for HEMS-assisted patients were €39 200 ( Table   2 ). The main costs related to length of hospital admission (€10 300) and intensive care stay (€16 100). The average costs for an ambulance-assisted patient were significantly lower at €34 500 (P=0.016). This difference was due mainly to costs for intensive care and diagnostic modalities, resulting in incremental costs for medical care of €4700 per HEMS-assisted patient.
+B: Cost-effectiveness analysis
The costs for the 4 years of HEMS assistance totalled €11 314 972 (€5 574 878 for personnel and €5 740 094 for material costs). The total incremental costs of medical were €987 000 (€4700 for each of the 210 surviving HEMS patients over 4 years).
The total cost for HEMS assistance was calculated as €12 301 972 (actual HEMS cost of €11 314 972 plus the total incremental cost of €987 000). Based on these calculations, when using the recommended discount rate of 1.5 per cent, the costs for HEMS were €28 327 per QALY ( Table 3) . In a sensitivity analysis performed to test the effect of using different discount rates, the costs per QALY for HEMS when using a discount rate of 0.0 or 3.5 per cent were €16 000 and €62 000 respectively.
+A: Discussion
HEMS assistance is effective in saving the lives of moderately and severely injured trauma patients. The study population receiving HEMS assistance was more severely injured than those receiving only EMS assistance. The incremental costs for intramural care were €4700 for HEMS-treated patients, determined mainly by the costs of intensive care stay and diagnostic modalities used. Over the study interval, HEMS assistance saved a total of 29 additional lives. No statistically significant differences in quality of life were found between HEMS and EMS-assisted patients.
Two years after trauma, the mean EQ-5D utility score was 0.70 versus 0.71
respectively. The incremental cost-effectiveness ratio for the use of HEMS rather than EMS was €28 327 per QALY.
Functional outcome and quality of life of survivors of severe injury do not return to normal 2 years after trauma. The prevalence of specific limitations in this population is high (40-61 per cent), and differences between HEMS-and EMSassisted patients in the EQ-5D summary score and all specific health dimensions were small, non-significant and inconsistent. In previous studies 28, 29 , determinants of longterm functional consequences of major trauma have demonstrated good performance of EQ-5D in survivors of major trauma, in terms of discriminative power and sensitivity to change. As well validated instruments were used in the present study, the reported high prevalence of problems is a good reflection of the health situation of patients with major trauma.
The sensitivity analysis showed that the choice of discount rate greatly influenced the findings of the cost-effectiveness analysis. Use of a discount rate of 0 versus 3.5
per cent resulted in a cost-effectiveness ratio of €16 000 and €62 000 respectively.
Both of these values are below the acceptance threshold of €75 000 per QALY [12] [13] [14] .
To put these results of costs per QALY into greater perspective, comparison can be made with the costs of other treatment modalities regularly performed in the Netherlands. For example, for liver, heart and lung transplantation, the costs per QALY are €35 100, €36 800 and €79 500 respectively 30 .
The relatively low response rate of 56 per cent could be regarded as a limitation of the present study and may have affected the costs per QALY. Much of the study population was untraceable because the patients were not living in the Netherlands and were consequently lost to follow-up.
When the health status of the study population at 2 years after trauma was compared with quality-of-life measurements at 1 year in a comparable cohort during the same study interval, QoL at 2 years was slightly lower than that reported at 1 year (mean EQ-5D utility score 70 versus 73). This finding has been reported previously 31 .
A possible explanation is that patients with disturbed health status are more likely to participate in QoL measurements. In this case, the low response rate in the present study could have influenced the QoL score, and the actual health status of the whole study population might have been higher than measured. A better average health status would have resulted in lower costs per QALY.
With calculated incremental costs for medical care of €4700 per HEMS-assisted patient, the costs per QALY for HEMS in the Netherlands remain below the acceptance threshold. Thus, HEMS should be considered as cost effective. 
